MSCI [MSCI] vs CME [CME] Detailed Stock Comparison

MSCI

CME
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: MSCI wins in 6 metrics, CME wins in 14 metrics, with 0 ties. CME appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | MSCI | CME | Better |
---|---|---|---|
P/E Ratio (TTM) | 37.14 | 25.62 | CME |
Price-to-Book Ratio | -48.92 | 3.43 | MSCI |
Debt-to-Equity Ratio | -5.25 | 13.60 | MSCI |
PEG Ratio | 2.28 | 1.64 | CME |
EV/EBITDA | 27.58 | 21.35 | CME |
Profit Margin (TTM) | 39.46% | 58.59% | CME |
Operating Margin (TTM) | 54.55% | 66.87% | CME |
EBITDA Margin (TTM) | 54.55% | 66.87% | CME |
Return on Equity | -117.99% | 13.61% | CME |
Return on Assets (TTM) | 18.55% | 1.74% | MSCI |
Free Cash Flow (TTM) | $1.39B | $3.60B | CME |
Dividend Yield | 0.92% | 4.30% | CME |
1-Year Return | -6.02% | 18.89% | CME |
Price-to-Sales Ratio (TTM) | 14.51 | 14.83 | MSCI |
Enterprise Value | $47.65B | $97.06B | CME |
EV/Revenue Ratio | 15.95 | 15.09 | CME |
Gross Profit Margin (TTM) | 82.18% | 86.90% | CME |
Revenue per Share (TTM) | $38 | $18 | MSCI |
Earnings per Share (Diluted) | $15.08 | $10.33 | MSCI |
Beta (Stock Volatility) | 1.33 | 0.43 | CME |
MSCI vs CME Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
MSCI | 0.76% | 0.30% | -0.95% | -3.21% | 12.35% | -4.69% |
CME | 0.59% | -2.44% | 0.39% | -6.71% | 4.45% | 13.27% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
MSCI | -6.02% | 46.41% | 55.66% | 845.68% | 1,486.15% | 2,180.09% |
CME | 18.89% | 53.42% | 56.91% | 193.21% | 392.71% | 315.51% |
News Based Sentiment: MSCI vs CME
MSCI
News based Sentiment: MIXED
October presented a mixed bag for MSCI, with bullish analyst upgrades and positive earnings reports countered by a price target reduction and concerns about subscription growth. The company's financial moves and product launches add complexity, making it a significant but nuanced month for investors.
CME
News based Sentiment: POSITIVE
CME Group is showing strong performance in both its traditional markets and its expanding cryptocurrency offerings. Analyst upgrades, insider buying, and record trading volumes in crypto all contribute to a positive outlook, making this a significant month for the company.
Performance & Financial Health Analysis: MSCI vs CME
Metric | MSCI | CME |
---|---|---|
Market Information | ||
Market Cap | $43.33B | $96.97B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 580,330 | 1,751,020 |
90 Day Avg. Volume | 681,050 | 1,905,747 |
Last Close | $569.11 | $263.60 |
52 Week Range | $486.74 - $642.45 | $213.94 - $290.79 |
% from 52W High | -11.42% | -9.35% |
All-Time High | $679.85 (Nov 15, 2021) | $290.79 (Jun 02, 2025) |
% from All-Time High | -16.29% | -9.35% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.09% | 0.10% |
Quarterly Earnings Growth | 0.14% | 0.16% |
Financial Health | ||
Profit Margin (TTM) | 0.39% | 0.59% |
Operating Margin (TTM) | 0.55% | 0.67% |
Return on Equity (TTM) | -1.18% | 0.14% |
Debt to Equity (MRQ) | -5.25 | 13.60 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $-11.46 | $77.13 |
Cash per Share (MRQ) | $4.44 | $5.82 |
Operating Cash Flow (TTM) | $1.49B | $4.20B |
Levered Free Cash Flow (TTM) | $1.12B | $2.92B |
Dividends | ||
Last 12-Month Dividend Yield | 0.92% | 4.30% |
Last 12-Month Dividend | $5.00 | $11.85 |
Valuation & Enterprise Metrics Analysis: MSCI vs CME
Metric | MSCI | CME |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 37.14 | 25.62 |
Forward P/E | 32.87 | 25.52 |
PEG Ratio | 2.28 | 1.64 |
Price to Sales (TTM) | 14.51 | 14.83 |
Price to Book (MRQ) | -48.92 | 3.43 |
Market Capitalization | ||
Market Capitalization | $43.33B | $96.97B |
Enterprise Value | $47.65B | $97.06B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 15.95 | 15.09 |
Enterprise to EBITDA | 27.58 | 21.35 |
Risk & Other Metrics | ||
Beta | 1.33 | 0.43 |
Book Value per Share (MRQ) | $-11.46 | $77.13 |
Financial Statements Comparison: MSCI vs CME
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | MSCI | CME |
---|---|---|
Revenue/Sales | $745.83M | $1.64B |
Cost of Goods Sold | $136.79M | $206.70M |
Gross Profit | $609.04M | $1.44B |
Research & Development | $47.59M | N/A |
Operating Income (EBIT) | $377.02M | $1.11B |
EBITDA | $432.11M | $476.30M |
Pre-Tax Income | $331.07M | $1.24B |
Income Tax | $42.47M | $288.60M |
Net Income (Profit) | $288.60M | $956.20M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | MSCI | CME |
---|---|---|
Cash & Equivalents | $343.68M | $1.41B |
Total Current Assets | $1.27B | $123.45B |
Total Current Liabilities | $1.47B | $121.42B |
Long-Term Debt | $4.63B | $3.42B |
Total Shareholders Equity | $-886.21M | $27.03B |
Retained Earnings | $5.09B | $4.69B |
Property, Plant & Equipment | $202.79M | $371.20M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | MSCI | CME |
---|---|---|
Operating Cash Flow | $308.74M | $838.30M |
Capital Expenditures | N/A | $-14.20M |
Free Cash Flow | $301.58M | $1.10B |
Debt Repayment | $-149.88M | $-750.00M |
Common Stock Repurchase | $-138.49M | N/A |
Short Interest & Institutional Ownership Analysis
Metric | MSCI | CME |
---|---|---|
Shares Short | 1.34M | 4.63M |
Short Ratio | 2.13 | 2.42 |
Short % of Float | 0.02% | 0.01% |
Average Daily Volume (10 Day) | 580,330 | 1,751,020 |
Average Daily Volume (90 Day) | 681,050 | 1,905,747 |
Shares Outstanding | 77.74M | 359.61M |
Float Shares | 74.70M | 358.80M |
% Held by Insiders | 0.03% | 0.00% |
% Held by Institutions | 0.95% | 0.92% |
Dividend Analysis & Yield Comparison: MSCI vs CME
Metric | MSCI | CME |
---|---|---|
Last 12-Month Dividend | $5.00 | $11.85 |
Last 12-Month Dividend Yield | 0.92% | 4.30% |
3-Year Avg Annual Dividend | $5.41 | $10.10 |
3-Year Avg Dividend Yield | 0.27% | 0.91% |
3-Year Total Dividends | $16.22 | $30.30 |
Ex-Dividend Date | Feb 14, 2025 | Sep 09, 2025 |